Skip to main content
Signal8

Endovia Health Sciences, Inc. (SBEV) Form 8-K — Oct 27, 2026

$SBEVForm 8-KItems 1.01, 9.01Filed Oct 27, 2026, 4:10 PM ET0001731122-26-001375Original filing

Endovia Health Sciences (formerly Splash Beverage Group) entered into an Addendum on October 22, 2026 to its September 2025 equity line of credit with C/M Capital Master Fund, LP, increasing the total maximum commitment from $35 million to $135 million. The incremental $100 million is drawn via Fixed Purchases, VWAP Purchases, and Additional VWAP Purchases over up to 36 months, priced at 95% of recent market prices, with a $0.10 minimum stock price condition, a 19.99% exchange cap, and a 4.99% investor beneficial ownership cap.

Key figures

Gross Proceeds
$135,000,000 total maximum commitment (increased from $35,000,000)
Exchange cap
19.99% of outstanding shares
Commitment fee
2% of Commitment Amount
Commitment period
Up to 36 months
Minimum price floor
$0.10
Expense reimbursement
$35,000
Initial shares issued
10875000
Purchase price discount
95% of lower of prior-day low or 5-day VWAP
Beneficial ownership cap
4.99%
Aggregate vwap max per day
$2,000,000
Max fixed purchase per day
$10,000,000
New incremental commitment
$100,000,000

AI analysis

Red flags5 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.